GottfriedEKonecnyMD
Oncology • Los Angeles, CAGynecologic Cancer
Associate Professor, Medicine, University of California Los Angeles David Geffen SOM
Dr. Konecny is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 UCLA Medical Plz Ste 550
Los Angeles, CA 90024Phone+1 310-206-1214
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gynecologic Oncology, 2005 - 2007
Ludwig Maximilian University of Munich Faculty of MedicineClass of 1989
Certifications & Licensure
CA State Medical License 2013 - 2026
Clinical Trials
- Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer Start of enrollment: 2009 Jan 01
- Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer Start of enrollment: 2009 Jan 01
- Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer Start of enrollment: 2011 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Antibody-drug conjugates as targeted therapy for treating gynecologic cancers: update 2025.Jordyn Silverstein, Beth Karlan, Nasim Herrington, Gottfried Konecny
Current Opinion in Obstetrics & Gynecology. 2025-02-01 - Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein Biomarkers.Jamie E Medina, Akshaya V Annapragada, Pien Lof, Sarah Short, Adrianna L Bartolomucci
Cancer Discovery. 2025-01-13 - ZNFX1 functions as a master regulator of epigenetically induced pathogen mimicry and inflammasome signaling in cancer.Lora Stojanovic, Rachel Abbotts, Kaushelendra Tripathi, Collin M Coon, Saranya Rajendran
Cancer Research. 2025-01-13
Press Mentions
Targeted Therapy for Early Breast Cancer and Advances in PSMA PET Scans at ASCOMay 22nd, 2023- UCLA Joins Clinical Trial to Study COVID-19 in People with CancerSeptember 15th, 2020
OncLive® Presents State of the Science Summit™ on Ovarian CancerJune 17th, 2019- Join now to see all
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
